Avata Biosciences
PrivateLast Round
Strategic
Jun 17, 2025
Total Funding Raised
$95M
Company Overview
Avata Biosciences is a biopharmaceutical company that develops synthetic cannabinoid-based medicines for the treatment of neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avata Biosciences Comparables
Compare Avata Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jazz Pharmaceuticals | 71% | |
| Harmony Biosciences Holdings, Inc. | 69% | |
| Ananda Pharma plc | 68% | |
Avata Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 17, 2025 | ||||
| VC Round | May 13, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors increased 171% MoM.
- May 13, 2024
$110M raised in a VC Round.
Avata Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avata Biosciences's valuation, stock price, and market status.